As the U.S. begins to escalate their response against H5N1 bird flu, we will likely see a push for more unsafe and ineffective countermeasures. The Biopharmaceutical Complex is currently preparing bird flu mRNA injections developed by ModernaCEPI-funded H5N1 replicon (self-amplifying) shots, and Arcturus Therapeutics replicon ‘pandemic’ bird flu injections funded by BARDA and the Gates Foundation. Thus, it is of high priority to identify promising compounds with anti-avian influenza activity that don’t involve injection of modified genetic material.

https://petermcculloughmd.substack.com/p/natural-compounds-that-target-and